SIM
TEVA icon

Sandia Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sandia Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$102K – 202
2023
Q3 		$102K Hold
10,000
– – 0.03% 146
2023
Q2 		$75.3K Buy
+10,000
New +$81.1K 0.02% 166

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sandia Investment Management's TEVA Position: Q4 2023 in Review

Sandia Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 10,000 shares — an estimated $102K sold.

Sandia Investment Management first reported a position in TEVA in Q2 2023 and held it in 2 quarters. The position peaked at $102K in Q3 2023. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Sandia Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Sandia Investment Management sold 10,000 Teva Pharmaceuticals shares in Q4 2023, an estimated $102K.
  • Sandia Investment Management first reported a position in Teva Pharmaceuticals in Q2 2023 and held it in 2 quarters.
  • Sandia Investment Management's Teva Pharmaceuticals position peaked at $102K in Q3 2023.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Sandia Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.